Immune checkpoint inhibitors for cutaneous T-cell lymphoma
The use of immunophenotyping to assess minimal residual disease (MRD) in multiple myeloma
Dendritic cell vaccine for MM: progress so far
How does an understanding of the microenvironment aid research in CLL?
Looking beyond the leukemic cell for answers
Christopher Pepper et al.